Thursday 27 August 2009

Medivet Trio S




Medivet Trio S may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Medivet Trio S



Sulfadimidine

Sulfadimidine is reported as an ingredient of Medivet Trio S in the following countries:


  • Switzerland

Sulfathiazole

Sulfathiazole is reported as an ingredient of Medivet Trio S in the following countries:


  • Switzerland

Trimethoprim

Trimethoprim is reported as an ingredient of Medivet Trio S in the following countries:


  • Switzerland

International Drug Name Search

Saturday 22 August 2009

Biafine Emulsion


Pronunciation: i-MUL-shun
Generic Name: Wound Dressing
Brand Name: Biafine


Biafine Emulsion is used for:

Treating minor cuts, burns (including sunburns), and wounds; pressure sores; skin ulcers; skin graft or donor sites; or skin inflammation caused by radiation treatment. It may also be used for other skin conditions as determined by your doctor.


Biafine Emulsion is a wound dressing. It works by providing moisture for the healing process and protecting the healing wound from contamination.


Do NOT use Biafine Emulsion if:


  • you are allergic to any ingredient in Biafine Emulsion

  • you have a bleeding wound

  • you have a skin rash caused by an allergic reaction to food or medicine

Contact your doctor or health care provider right away if any of these apply to you.



Before using Biafine Emulsion:


Some medical conditions may interact with Biafine Emulsion. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you are or will be receiving radiation therapy

  • if you have signs of an infection (eg, redness, swelling) at the application site

Some MEDICINES MAY INTERACT with Biafine Emulsion. Because little, if any, of Biafine Emulsion is absorbed into the blood, the risk of it interacting with another medicine is low.


Ask your health care provider if Biafine Emulsion may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Biafine Emulsion:


Use Biafine Emulsion as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Wash your hands before using Biafine Emulsion.

  • If you are using Biafine Emulsion on a wound or a skin graft or donor site, wash the affected area with saline, water, or wound cleanser. Apply a 1 4 - to ½-inch-thick layer of medicine to the affected area. If you will be using gauze dressing, moisten the dressing lightly before applying it on the wound.

  • If you are using Biafine Emulsion on a skin graft, apply it only after the graft has successfully taken. If you need to wash Biafine Emulsion off, you may use a saline solution or clean water.

  • If you are using Biafine Emulsion for minor burns, including sunburns, be sure to remove any clothing from the affected area before you apply it. Apply a 1 4 - to ½-inch-thick layer to the affected area. Gently rub in until the skin no longer absorbs the medicine. A white waxy residue may remain. If pain persists, apply thin layers of Biafine Emulsion until the pain goes away. Contact your doctor if the pain does not stop or if it worsens.

  • If you are using Biafine Emulsion for skin inflammation caused by radiation treatment, gently massage it into the affected area until it is completely absorbed. Do not stop using Biafine Emulsion during treatment, even for one day, unless your doctor tells you otherwise. Do not apply Biafine Emulsion within 4 hours before radiation treatment.

  • Wash your hands after using Biafine Emulsion, unless your hands are a part of the treated area.

  • Continue to use Biafine Emulsion as directed by your doctor until your skin has fully healed. Do not miss any doses.

  • If you miss a dose of Biafine Emulsion, use it as soon as you remember. Continue to use it as directed by your doctor.

Ask your health care provider any questions you may have about how to use Biafine Emulsion.



Important safety information:


  • Biafine Emulsion is for external use only. Do not get it in your eyes, nose, or mouth. If you get it in your eyes, rinse right away with cool tap water.

  • Talk with your doctor before you use any other medicines or cleansers on your skin.

  • Biafine Emulsion does not contain sunscreen. Ask your doctor before use if you must be outside for more than a short time.

  • If your symptoms do not get better within 10 to 14 days or if they get worse, check with your doctor.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Biafine Emulsion while you are pregnant. If you are or will be breast-feeding while you use Biafine Emulsion, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Biafine Emulsion:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Tingling.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Biafine side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Biafine Emulsion:

Store Biafine Emulsion at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Do not freeze. Keep Biafine Emulsion out of the reach of children and away from pets.


General information:


  • If you have any questions about Biafine Emulsion, please talk with your doctor, pharmacist, or other health care provider.

  • Biafine Emulsion is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Biafine Emulsion. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Biafine resources


  • Biafine Side Effects (in more detail)
  • Biafine Use in Pregnancy & Breastfeeding
  • Biafine Support Group
  • 2 Reviews for Biafine - Add your own review/rating


Compare Biafine with other medications


  • Dry Skin

Laproton




Laproton may be available in the countries listed below.


Ingredient matches for Laproton



Lansoprazole

Lansoprazole is reported as an ingredient of Laproton in the following countries:


  • Indonesia

International Drug Name Search

Raspjine




Raspjine may be available in the countries listed below.


Ingredient matches for Raspjine



Azelastine

Azelastine hydrochloride (a derivative of Azelastine) is reported as an ingredient of Raspjine in the following countries:


  • Japan

International Drug Name Search

Monday 17 August 2009

Tromic




Tromic may be available in the countries listed below.


Ingredient matches for Tromic



Azithromycin

Azithromycin is reported as an ingredient of Tromic in the following countries:


  • Dominican Republic

International Drug Name Search

Friday 14 August 2009

Enalapril Cinfa




Enalapril Cinfa may be available in the countries listed below.


Ingredient matches for Enalapril Cinfa



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril Cinfa in the following countries:


  • Portugal

  • Spain

International Drug Name Search

Thursday 13 August 2009

Acatar Zatoki




Acatar Zatoki may be available in the countries listed below.


Ingredient matches for Acatar Zatoki



Ibuprofen

Ibuprofen is reported as an ingredient of Acatar Zatoki in the following countries:


  • Poland

Pseudoephedrine

Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Acatar Zatoki in the following countries:


  • Poland

International Drug Name Search

Friday 7 August 2009

Dicyclomine




In the US, Dicyclomine (dicyclomine systemic) is a member of the drug class anticholinergics/antispasmodics and is used to treat Irritable Bowel Syndrome.

US matches:

  • Dicyclomine

  • Dicyclomine Capsules

  • Dicyclomine Syrup

  • Dicyclomine Hydrochloride

  • Dicyclomine Injection

  • Dicyclomine Tablets

Ingredient matches for Dicyclomine



Dicycloverine

Dicyclomine (BAN) is also known as Dicycloverine (Rec.INN)

International Drug Name Search

Glossary

BANBritish Approved Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Carboplatino




Carboplatino may be available in the countries listed below.


Ingredient matches for Carboplatino



Carboplatin

Carboplatino (DCIT) is known as Carboplatin in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Amantadin-HCl Sandoz




Amantadin-HCl Sandoz may be available in the countries listed below.


Ingredient matches for Amantadin-HCl Sandoz



Amantadine

Amantadine hydrochloride (a derivative of Amantadine) is reported as an ingredient of Amantadin-HCl Sandoz in the following countries:


  • Germany

International Drug Name Search

Tuesday 4 August 2009

Unakalm




Unakalm may be available in the countries listed below.


Ingredient matches for Unakalm



Ketazolam

Ketazolam is reported as an ingredient of Unakalm in the following countries:


  • Portugal

International Drug Name Search